NCT05862259View on ClinicalTrials.gov

A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies

RecruitingOBSERVATIONAL

Enrollment

120

Participants

Timeline

Start Date

August 10, 2023

Primary Completion Date

August 10, 2025

Study Completion Date

December 31, 2025

Conditions

Malignant TumorImmunotherapyArtificial Intelligence

Trial Locations (1)

40037

RECRUITING

the second affiliated hospital of Army medical university, Chongqing

All Listed Sponsors

lead

Xinqiao Hospital of Chongqing

OTHER